MAIA Biotechnology Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.1% | +15.2% | +37.9% | -23.1% | +9.9% | +16.8% | -6.9% | +6.7% | -17.6% | +264.0% | -20.1% | |
| – | +14.0% | +15.0% | +38.1% | -23.1% | +9.9% | +16.8% | -6.9% | +6.4% | -17.5% | +264.0% | -20.0% | |
| – | +17.1% | +15.7% | +40.0% | -24.9% | +10.5% | +13.1% | -6.6% | +7.4% | -20.5% | +297.5% | -19.8% | |
| – | +17.1% | +15.7% | +40.0% | -24.9% | +10.5% | +13.1% | -6.6% | +7.4% | -20.5% | +297.5% | -19.8% | |
| – | +26.4% | +7.8% | +13.9% | -69.8% | +44.3% | +1.0% | +5.4% | +0.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +66.7% | +104.3% | -38.8% | -13.9% | -14.5% | +6.2% | +3.6% | +63.8% | -37.6% | +3.2% | +0.1% | |
| – | +19.0% | -0.6% | -28.5% | +2.8% | +6.1% | +32.0% | -0.3% | +98.1% | -41.6% | +8.3% | -1.0% | |
| – | +33.6% | +14.3% | -32.5% | -8.8% | +31.3% | +21.7% | -6.4% | +84.3% | -35.8% | +46.3% | -4.8% | |
| – | -82.6% | -1,307.3% | – | -48.8% | +124.6% | +36.0% | -21.6% | -98.9% | +5,601.6% | +1,068.5% | -25.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +24.2% | +3.6% | +26.1% | +7.6% | +9.5% | +5.9% | +9.4% | +9.6% | -3.3% | +0.0% | +89.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.